116 results
Page 2 of 6
POS AM
nxewn6ae mblos
11 May 22
Prospectus update (post-effective amendment)
5:20pm
POS AM
nugabibzav w2fmj
11 May 22
Prospectus update (post-effective amendment)
5:19pm
6-K
acuk1 8vmrtpotktg
11 May 22
Current report (foreign)
4:30pm
6-K
h1s 3x0ati
4 May 22
Amryt Reports Record Q1 2022 Results
7:43am
6-K
yez1ck rsvpzbz1j21
31 Mar 22
Results of General Meeting
8:41am
6-K
zolral6t 21ic
16 Mar 22
Current report (foreign)
8:30am
6-K
8lln1br
9 Mar 22
Amryt Announces 22% growth in FY 2021 Revenues to $222.5M
9:23am
6-K
mzndj5 gs0mvir0
28 Feb 22
Amryt Receives Complete Response Letter from the FDA for Oleogel-S10 NDA
12:00pm
6-K
ep53g2c0z8uz67
25 Feb 22
Current report (foreign)
4:05pm
6-K
mcgof8eu
31 Jan 22
Current report (foreign)
7:32am
6-K
iaelz6adnrv
23 Nov 21
Amryt Provides Update on Regulatory Review Process for Oleogel-S1
8:04am
424B3
b0epp
22 Nov 21
Prospectus supplement
7:39am
424B3
uek3eugec2r
22 Nov 21
Prospectus supplement
7:38am
6-K
EX-99.3
6s8jpy53hi5s89qfl
22 Nov 21
Amryt Announces the Cancellation of Admission of its Ordinary Shares to Trading on AIM
7:37am
6-K
u3n0fqu 1su
22 Nov 21
Amryt Announces the Cancellation of Admission of its Ordinary Shares to Trading on AIM
7:37am
424B3
2f3oso ttv1lw
3 Nov 21
Prospectus supplement
7:33am
424B3
shmtpsyzp0nl bx
3 Nov 21
Prospectus supplement
7:32am
6-K
c4wgd
3 Nov 21
Amryt Reports Strong Q3 2021 Results
7:31am
6-K
y2fnc n1eyf
29 Oct 21
Current report (foreign)
6:05am